Ventyx Biosciences, Inc. (VTYX) Misses Q2 EPS by 21c

Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q2 EPS of ($0.91), $0.21 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
• Waste stocks ride AI and healthcare boom as CLH surges 27%